These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6120901)

  • 1. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evaluation of the beta-blocking properties and direct membrane effects of l-moprolol and its enantiomer d-moprolol.
    Porciatti F; Cerbai E; Masini I; Mugelli A
    Arch Int Pharmacodyn Ther; 1989; 299():200-9. PubMed ID: 2570555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
    Haustein KO; Fritzsche K
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man.
    Houin G; Barre J; Jeanniot JP; Ledudal P; Cautreels W; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):175-83. PubMed ID: 6149195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic parameters of bevantolol in volunteers.
    Vermeij P; van Brummelen P
    Eur J Clin Pharmacol; 1986; 30(3):375-7. PubMed ID: 2874033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerability of high doses of (-)-moprolol in healthy volunteers.
    Triulzi MO; Balice G; Gentile F; Rossini GL; Fattori CM
    Eur J Clin Pharmacol; 1982; 22(4):377-8. PubMed ID: 6125397
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Li F; Bi H; Côté M; Cooper S
    J Chromatogr; 1993 Dec; 622(2):187-95. PubMed ID: 7908669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
    Ohashi K; Ebihara A; Kondo K; Usami M
    Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of (-) moprolol in man: double-blind comparison of enantiomers.
    Ghirardi P; Grosso F
    J Cardiovasc Pharmacol; 1980; 2(4):471-2. PubMed ID: 6156344
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.
    Kawashima K; Ishikawa H
    J Pharmacol Exp Ther; 1980 Jun; 213(3):628-31. PubMed ID: 6110769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.